Frontier Peptide Labs manufactures BPC/TB capsules under strict quality control standards with attention to formulation consistency, research material identity, capsule composition, and reproducibility for laboratory research
Phase 1: Activation (Weeks 14) Dose: 1.64.8 mg Daily GHK-Cu activates collagen production while its copper component enables proper structural cross-linking BPC-157 builds the network of small blood vessels needed to feed active tissue TB-4 mobilizes and organizes repair cells KPV simultaneously suppresses inflammatory interference Expected: Skin hydration improves, tone evens, texture softens, redness decreases
It also may help vaginal dryness and irritation, though vaginal estrogen would likely give more relief
Critically, GHK-Cu delivers copper as cofactor for lysyl oxidase and lysyl hydroxylase, copper-dependent enzymes essential for collagen cross-linking and stability
The following findings summarize expanded preclinical evidence: 1